|
NXF1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.002300E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.057110E-03 |
| Normal-vs-Stage2 |
7.566800E-01 |
| Normal-vs-Stage3 |
4.855400E-01 |
| Normal-vs-Stage4 |
7.037400E-01 |
| Stage1-vs-Stage2 |
5.057200E-03 |
| Stage1-vs-Stage3 |
6.942400E-03 |
| Stage1-vs-Stage4 |
3.255700E-02 |
| Stage2-vs-Stage3 |
3.752200E-01 |
| Stage2-vs-Stage4 |
5.565600E-01 |
| Stage3-vs-Stage4 |
8.701800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.357530E-02 |
| Normal-vs-AfricanAmerican |
1.649180E-01 |
| Normal-vs-Asian |
1.042230E-02 |
| Caucasian-vs-AfricanAmerican |
8.978400E-01 |
| Caucasian-vs-Asian |
9.866500E-02 |
| AfricanAmerican-vs-Asian |
1.299380E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.089620E-01 |
| Normal-vs-Female |
1.905830E-02 |
| Male-vs-Female |
6.407000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.973000E-04 |
| Normal-vs-Age(41-60Yrs) |
4.100000E-02 |
| Normal-vs-Age(61-80Yrs) |
3.119800E-01 |
| Normal-vs-Age(81-100Yrs) |
6.237800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.364000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.53109999999623E-05 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.943940E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.856900E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.220300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.780800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.040600E-03 |
| Classical-VS-Follicular |
1.49040000341216E-08 |
| Classical-VS-Other |
8.263200E-01 |
| Classical-VS-Normal |
1.439400E-04 |
| Tall-VS-Follicular |
2.443800E-01 |
| Tall-VS-Other |
3.652200E-01 |
| Tall-VS-Normal |
9.170800E-01 |
| Follicular-VS-Other |
2.216000E-01 |
| Follicular-VS-Normal |
8.779700E-02 |
| Other-VS-Normal |
3.720000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.125200E-01 |
| Normal-vs-N1 |
1.014000E-01 |
| N0-vs-N1 |
2.220600E-01 |
|
|
